Last reviewed · How we verify

NCT03035266

The Effect of Blood Flow Restriction Training on Muscle Atrophy Following Knee Surgery

Completed NA Last updated 21 August 2020
What this trial tests

NA trial testing Blood Flow Restriction in Knee Injuries in 22 participants. Completed in 12 March 2020.

Timeline
5 April 2017
Primary endpoint
12 March 2020
12 March 2020

Quick facts

Lead sponsorKeller Army Community Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment22
Start date5 April 2017
Primary completion12 March 2020
Estimated completion12 March 2020
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Keller Army Community Hospital

Who can join

Adults 18 to 50, any sex, with Knee Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators will compare differences in quadriceps strength, leg girth, and functional outcome scores between two groups of patients after weeks 6 and 12 as well as 6 months following meniscus or articular cartilage repair/restoration requiring 6 weeks of non-weight bearing or limited weight bearing status in a brace at 0° degrees of knee extension. One group will receive BFR with standard post-operative rehabilitation for 12 weeks followed by the standard protocol progression for the remainder of the treatment program. The other group will receive standard post-operative rehabilitation without BFR for the duration of treatment program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Blood Flow Restriction

Trials testing the same drug.

Other recruiting trials for Knee Injuries

Currently open trials in the same condition.

Other Keller Army Community Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03035266.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing